Skip to main content

Peer Review reports

From: Efficacy and safety of fluzoparib combined with anlotinib in extensive stage small cell lung cancer after first-line platinum-based chemotherapy: a multi-center, single-arm prospective phase II clinical study (STAMP study)

Original Submission
24 Jan 2022 Submitted Original manuscript
25 May 2022 Reviewed Reviewer Report
11 Aug 2022 Reviewed Reviewer Report
10 Oct 2022 Author responded Author comments - Deyu Li
Resubmission - Version 2
10 Oct 2022 Submitted Manuscript version 2
23 Mar 2023 Reviewed Reviewer Report
23 May 2023 Author responded Author comments - Deyu Li
Resubmission - Version 3
23 May 2023 Submitted Manuscript version 3
4 Jun 2023 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
21 Jul 2023 Editorially accepted
14 Aug 2023 Article published 10.1186/s12885-023-11230-5

You can find further information about peer review here.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us